Skip to main content
Log in

Progress in the management of fulminant hepatic failure

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Trey C, Davidson CS (1970) The management of fulminant hepatic failure. In: Popper H, Schaffner F (eds) Progress in liver disease, vol III. Grune and Stratton, New York, pp 282–298

    Google Scholar 

  2. Gimson AES, Canalese J, Hughes RD, Williams R (1980) Management of fulminant hepatic failure. Update 6: 1161–1170

    Google Scholar 

  3. Chang MY, Campbell WG Jr (1975) Fatal infectious mononucleosis: association with liver necrosis and herpes like virus particles. Arch Pathol 99: 185–191

    Google Scholar 

  4. Henson DE, Crimley PM, Strane AJ (1974) Postnatal cytomegalovirus hepatitis: an autopsy and liver biopsy study. Hum Pathol 5:93

    Google Scholar 

  5. Francis TI, Osuntokum BO, Kemp GE (1972) Fulminant hepatitis due to herpes hominis in an adult human. Am J Gastroenterol 57:329–332

    Google Scholar 

  6. Hanid MA, Silk DBA, Williams R (1978) Prognostic value of the oculovestibular reflex in fulminant hepatic failure. Br Med J 1:1029–1030

    Google Scholar 

  7. Canalese J, Gimson AES, Davis M, Williams R (1981) Factors contributing to mortality in paracetamol induced hepatic failure. Br Med J 1:199–201

    Google Scholar 

  8. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R (1975) Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 44:615–626

    Google Scholar 

  9. Wyke RJ, Rajkovic IA, Eddleston ALWF, Williams R (1980), Detective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut 21:643–649

    Google Scholar 

  10. Yousif-Kadaru AM, Wyke RJ, Rajkovic IA, Eddleston ALWF, Williams R (1980) Serum factors affecting movement of leucocytes in patients with fulminant hepatic failure. Clin Sci 58:14

    Google Scholar 

  11. Bailey RJ, MacDougall BRD, Williams R (1976) A controlled trial of the H2 antagonists in prophylaxis of bleeding from gastrointestinal tract erosions in fulminant hepatic failure. Gut 17:389

    Google Scholar 

  12. MacDougall BRD, Bailey RJ, Williams R (1977) H2 receptor antagonists and antacids in the presentation of acute upper gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1:617–619

    Google Scholar 

  13. Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–145

    Google Scholar 

  14. Record CO, Iles RA, Cohen RD, Williams R (1975) Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 16:144–149

    Google Scholar 

  15. Wilkinson SP, Blendis LM, Williams R (1974) Frequency and type of renal and electrolyte abnormalities in fulminant hepatic failure. Br Med J 1:186–189

    Google Scholar 

  16. Wilkinson SP, Arroyo VA, Moodie H, Blendis LM, Williams R (1976) Abnormalities of sodium excretion and other disorders or renal function in fulminant hepatic failure. Gut 17:501–505

    Google Scholar 

  17. Alam AN, Wilkinson SP, Poston L, Moodie H, Williams R (1977) Intracellular electrolyte abnormalities in fulminant hepatic failure. Gastroenterology 72:914–919

    Google Scholar 

  18. Weston MJ, Talbot K, Howarth PJH, Mant AK, Capildeo R, Williams R (1976) Frequency of arrythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J 38:1179–1182

    Google Scholar 

  19. Trewby PN, Warren R, Contini S, et al. (1978) Incidence and pathophysiology of pulmonary oedema in fulminant hepatic failure. Gastroenterology 74:859–865

    Google Scholar 

  20. Silk DBA, Hanid MA, Trewby PN, et al. (1977) Treatment of fulminant hepatic failure by polyacrylonitrile haemodialysis. Lancet 2:1–3

    Google Scholar 

  21. Hanid MA, Davis M, Mellon PJ, et al. (1980) Clinical monitoring intracranial pressure in fulminant hepatic failure. Gut 21:866–869

    Google Scholar 

  22. Opolon P, Lavallard MC, Huguet CI, et al. (1976) Haemodialysis versus cross haemodialysis in experimental hepatic coma. Surg Gynaecol Obstet 142:845–854

    Google Scholar 

  23. Bloch P, Delosme ML, Rapin JR, Boschat M, Opolon P (1978) Reversible modifications of brain neurotransmitters in experimental acute hepatic coma. Surg Gynaecol Obstet 146:551–558

    Google Scholar 

  24. Hughes RD, Cochrane AMG, Thomson AD, Murray-Lyon IM, Williams R (1976) The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 57:348–353

    Google Scholar 

  25. Weston MJ, Langley PJ, Rubin MH, Hanid MA, Mellon PJ, Williams R (1977) Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion. Gut 18:897–902

    Google Scholar 

  26. Gimson AES, Langley PJ, Hughes RD, et al. (1980) Prostacyclin to prevent platelet activation during charcoal haemoperfusion. Lancet 1:173–174

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braude, S., Gimson, A.E.S. & Williams, R. Progress in the management of fulminant hepatic failure. Intensive Care Med 7, 101–103 (1981). https://doi.org/10.1007/BF01738610

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01738610

Navigation